Artificial intelligence is rapidly transforming biomedical research, accelerating drug discovery, protein engineering, and vaccine development. However, scientists are now warning that the same technologies capable of advancing medicine could also be misused to design dangerous pathogens, toxins, and potential bioweapons. A recent report published in Nature highlights growing concerns that increasingly powerful AI systems may lower the technical barriers required to create harmful biological agents, raising urgent questions about global biosecurity preparedness. Researchers caution that advanced AI models can already assist in predicting protein structures, designing novel biological molecules, and generating genetic sequences capabilities that, in the wrong hands, could potentially be exploited for harmful purposes.

      Experts emphasize that while there is no evidence of immediate large-scale misuse, the pace of AI development is outstripping current regulatory and safety frameworks. Concerns are particularly focused on open-access biological AI tools and the possibility that non-experts could eventually use such systems to engineer infectious agents or evade existing biosafety screening systems. At the same time, scientists stress that AI also offers powerful defensive opportunities, including improved pathogen surveillance, faster outbreak prediction, and enhanced biosecurity screening for synthetic DNA orders. The discussion has therefore shifted toward balancing innovation with responsible oversight, including stronger safeguards, international collaboration, ethical AI governance, and tighter monitoring of high-risk biological applications. As AI becomes increasingly integrated into life sciences, ensuring that technological progress strengthens rather than threatens global health security is emerging as a major public health priority.